Interim Report Q1 2023 (Only in Swedish)
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Revenues increased in the first quarter by 17.5 percent to 72.4 (61.6) after strong growth from both business units. “I am satisfied to see such strong growth compared to previous year given that the first quarter last year was a record quarter”, comments Torbjörn Sköld.
The gross profit amounted to 42.4 percent (44.8). Business unit Surgical Tables was affected by an unfavorable product and market mix, while Surgical Instruments was positively affected by the same factors. Operating profit, before one-time costs, amounted to 10.4 MSEK (7.6).
”Stille’s strategic and financial goals remain. With our high-quality products within surgical instruments and radiolucent surgical tables, we will operate in niche premium segments. 2023 has started well for Stille. We continue to deliver value to our customers, which creates good demand, strong growth and good cashflow”, concludes Stille’s CEO.
| MSEK | JAN-MAR 2023 |
JAN-MAR 2022 |
APR-MAR 2022/2023 |
JAN-DEC 2022 |
| Revenue | 72.4 | 61.6 | 257.1 | 246.3 |
| Gross Profit Margin, % | 42.4 | 44.8 | 42.9 | 45.3 |
| EBITDA, before one-time costs | 13.7 | 9.9 | 46.0 | 42.1 |
| EBITDA | 10.4 | 9.8 | 42.7 | 42.1 |
| Operating Profit, before one-time costs | 10.4 | 7.6 | 35.3 | 32.5 |
| Operating Profit | 7.1 | 7.5 | 32.0 | 32.4 |
| Operating Profit, % | 9.8 | 12.2 | 10.8 | 13.2 |
Torshälla, April 27th, 2023.
This information is such information that Stille AB is obliged to disclose according to the EU’s market abuse regulation. The information was, through the agency of the contact person, rendered for publication on April 27th, 2023, kl. 08.00 (CET).